JOHANNESBURG (Reuters) - South African researchers hope to next week resume a study using Johnson & Johnson's COVID-19 vaccine to immunise healthcare workers, one of the scientists leading the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback